Literature DB >> 22875305

Sleep and violence.

Maria Livia Fantini1, Monica Puligheddu, Alessandro Cicolin.   

Abstract

OPINION STATEMENT: Treatment of violent behaviors in sleep depends on the underlying condition and a correct identification of the causative disorder is mandatory. After eliminating possible precipitating factors, pharmacological treatment is often required to control violent sleep behaviors. Although no drugs are specifically approved for the treatment of parasomnias and placebo-controlled trials are lacking in these patient populations, clonazepam is considered the drug of choice in the management of both Non-REM and REM parasomnias. Benzodiazepines may cause unwanted side effects especially in older individuals and tolerance is sometime observed. Melatonin and pramipexole may represent alternative options in REM sleep behavior disorder. Hypnosis therapy may be considered in arousal disorders when pharmacological treatment is contraindicated or ineffective. Management of nocturnal frontal lobe epilepsy include a first-step pharmacological approach with antiepileptic drugs (eg, carbamazepine, oxcarbazepine or other drugs effective on partial seizures), but surgical options may be considered in drug refractory patients. The published evidence for the efficacy of various treatments relies mostly upon case series or case reports.

Entities:  

Year:  2012        PMID: 22875305     DOI: 10.1007/s11940-012-0187-4

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  42 in total

Review 1.  REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP.

Authors:  Carlos H Schenck; Mark W Mahowald
Journal:  Sleep       Date:  2002-03-15       Impact factor: 5.849

2.  The hypnotic treatment of sleepwalking in an adult.

Authors:  T S Eliseo
Journal:  Am J Clin Hypn       Date:  1975-04

Review 3.  Violence in sleep.

Authors:  Francesca Siclari; Ramin Khatami; Frank Urbaniok; Lino Nobili; Mark W Mahowald; Carlos H Schenck; Michel A Cramer Bornemann; Claudio L Bassetti
Journal:  Brain       Date:  2010-12       Impact factor: 13.501

4.  Oxcarbazepine in nocturnal frontal-lobe epilepsy: a further interesting report.

Authors:  Andrea Romigi; Maria G Marciani; Fabio Placidi; Laura R Pisani; Francesca Izzi; Federico Torelli; Chiara Prosperetti
Journal:  Pediatr Neurol       Date:  2008-10       Impact factor: 3.372

5.  Arousal reactions in sleepwalking and night terrors in adults: the role of respiratory events.

Authors:  Fabrice Espa; Yves Dauvilliers; Basile Ondze; Michel Billiard; Alain Besset
Journal:  Sleep       Date:  2002-12       Impact factor: 5.849

6.  The value of sleep deprivation as a diagnostic tool in adult sleepwalkers.

Authors:  Steve Joncas; Antonio Zadra; Jean Paquet; Jacques Montplaisir
Journal:  Neurology       Date:  2002-03-26       Impact factor: 9.910

7.  Elimination of sleepwalking in a seven-year-old boy.

Authors:  P W Clement
Journal:  J Consult Clin Psychol       Date:  1970-02

8.  Treatment of sleepwalking: a controlled study.

Authors:  W H Reid; I Ahmed; C A Levie
Journal:  Am J Psychother       Date:  1981-01

9.  Oxcarbazepine in children with nocturnal frontal-lobe epilepsy.

Authors:  G Praveen Raju; Dean P Sarco; Annapurna Poduri; James J Riviello; Ann Marie R Bergin; Masanori Takeoka
Journal:  Pediatr Neurol       Date:  2007-11       Impact factor: 3.372

10.  Diazepam in intractable sleepwalking: a pilot study.

Authors:  W H Reid; E A Haffke; C C Chu
Journal:  Hillside J Clin Psychiatry       Date:  1984
View more
  2 in total

Review 1.  Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.

Authors:  Ian R McGrane; Jonathan G Leung; Erik K St Louis; Bradley F Boeve
Journal:  Sleep Med       Date:  2014-10-13       Impact factor: 3.492

2.  Firing a loaded gun during sleep in an elderly man with a "perfect storm" of risk factors including severe obstructive sleep apnea.

Authors:  Francesca Ingravallo; Carlos H Schenck; Ernesto D'Aloja; Monica Puligheddu
Journal:  Sleep Breath       Date:  2017-10-16       Impact factor: 2.816

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.